1
|
Rieder HL, Declercq E, Rigouts L, Piubello A, Billo NE, Ba F, Trébucq A, Chiang CY, Portaels F. Armand Van Deun - pioneering public health physician (1953-2023). Int J Tuberc Lung Dis 2024; 28:68-69. [PMID: 38178291 DOI: 10.5588/ijtld.23.0520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2024] Open
Affiliation(s)
- H L Rieder
- Tuberculosis Consultant Services, Kirchlindach, Switzerland
| | - E Declercq
- Formerly Damien Foundation, Brussels, Belgium
| | - L Rigouts
- Institute of Tropical Medicine, Antwerp, Belgium
| | | | - N E Billo
- Public Health Consulting, Joensuu, Finland
| | - F Ba
- Laboratoire National de Référence des Mycobactéries, Dakar, Sénégal
| | - A Trébucq
- Independent Consultant, Paris, France
| | - C-Y Chiang
- International Union Against Tuberculosis and Lung Disease, Paris, France
| | - F Portaels
- Emerita, Institute of Tropical Medicine, Antwerp, Belgium
| |
Collapse
|
2
|
Chiang CY, El Sony A, Beyers N, Fanning A, Marks GB, Rieder HL, Billo NE. Obituary for Donald A. Enarson. Int J Tuberc Lung Dis 2022. [PMID: 35898134 DOI: 10.5588/ijtld.22.0327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- C-Y Chiang
- International Union Against Tuberculosis and Lung Disease, Paris, France, Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei, Taiwan, Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
| | - A El Sony
- Epidemiological Laboratory (Epi-Lab) for Public Health, Research and Development, Khartoum, Sudan
| | - N Beyers
- Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa
| | - A Fanning
- Global Health Initiative, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | - G B Marks
- International Union Against Tuberculosis and Lung Disease, Paris, France, University of New South Wales, Sydney, NSW, Australia
| | - H L Rieder
- Tuberculosis Consultant Services, Kirchlindach, Switzerland
| | - N E Billo
- Independent consultant, Joensuu, Finland
| |
Collapse
|
3
|
Chiang CY, Bissell K, Macé C, Perrin C, Marks G, Mortimer K, El Sony A, Aït-Khaled N, Enarson DA, Billo NE. The Asthma Drug Facility and the future management of asthma. Int J Tuberc Lung Dis 2022; 26:388-391. [PMID: 35505485 DOI: 10.5588/ijtld.22.0034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- C-Y Chiang
- International Union Against Tuberculosis and Lung Disease, Paris, France, Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
| | - K Bissell
- School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
| | - C Macé
- Independent consultant, Nantes, France
| | - C Perrin
- Independent consultant, Brittany, France
| | - G Marks
- International Union Against Tuberculosis and Lung Disease, Paris, France, Respiratory & Environmental Epidemiology, University of New South Wales, Sydney, NSW, Australia
| | - K Mortimer
- International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Medicine, University of Cambridge, Cambridge, UK, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
| | - A El Sony
- Epidemiological Laboratory (Epi-Lab) for Public Health, Research and Development, Khartoum, Sudan
| | - N Aït-Khaled
- International Union Against Tuberculosis and Lung Disease, Paris, France
| | - D A Enarson
- International Union Against Tuberculosis and Lung Disease, Paris, France
| | - N E Billo
- Independent consultant, Joensuu, Finland
| |
Collapse
|
4
|
Valiulis A, Bousquet J, Veryga A, Suprun U, Sergeenko D, Cebotari S, Borelli D, Pietikainen S, Banys J, Agache I, Billo NE, Bush A, Chkhaidze I, Dubey L, Fokkens WJ, Grigg J, Haahtela T, Julge K, Katilov O, Khaltaev N, Odemyr M, Palkonen S, Savli R, Utkus A, Vilc V, Alasevicius T, Bedbrook A, Bewick M, Chorostowska-Wynimko J, Danila E, Hadjipanayis A, Karseladze R, Kvedariene V, Lesinskas E, Münter L, Samolinski B, Sargsyan S, Sitkauskiene B, Somekh D, Vaideliene L, Valiulis A, Hellings PW. Correction to: Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases. Clin Transl Allergy 2020; 10:49. [PMID: 33292544 PMCID: PMC7672866 DOI: 10.1186/s13601-020-00357-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Collapse
Affiliation(s)
- Arunas Valiulis
- Department of Public Health, Institute of Health Sciences, and Clinic of Children's Diseases, Institute of Clinical Medicine, Vilnius University Faculty of Medicine, Vilnius, Lithuania.,European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium
| | - J Bousquet
- MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France. .,INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France. .,UMR‑S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France. .,Euforea, Brussels, Belgium. .,Charité, Berlin, Germany.
| | - A Veryga
- Minister of Health, Vilnius, Lithuania
| | - U Suprun
- Minister of Health, Kiev, Ukraine
| | - D Sergeenko
- Minister of Labour, Health and Social Affairs, Tbilisi, Georgia
| | - S Cebotari
- Minister of Health, Labour and Social Protection, Chișinău, Moldova
| | | | | | - J Banys
- Lithuianian Academy of Sciences, Vilnius, Lithuania
| | - I Agache
- Faculty of Medicine, Transylvania University, Brasov, Romania
| | - N E Billo
- Global Alliance Against Chronic Respiratory Diseases (GARD), Joensuu, Finland
| | - A Bush
- Imperial College and Royal Brompton Hospital, London, UK
| | - I Chkhaidze
- Department of Pediatrics, and Iashvili Central Children's Hospital, Tbilisi State Medical University, Tbilisi, Georgia
| | - L Dubey
- Faculty of Postgraduate Education, Lviv National Medical University by Danylo Halytsky, Lviv, Ukraine
| | - W J Fokkens
- Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands
| | - J Grigg
- Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK
| | - T Haahtela
- Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - K Julge
- Children's Clinic, Tartu University Institute of Clinical Medicine, Tartu, Estonia
| | - O Katilov
- Vinnytsa National Medical University by Mykola Pyrogov, Vinnytsa, Ukraine
| | - N Khaltaev
- Global Alliance Against Chronic Respiratory Diseases (GARD-WHO), Geneva, Switzerland
| | - M Odemyr
- European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - S Palkonen
- European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - R Savli
- European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - A Utkus
- Department of Human and Medical Genetics, Institute of Biomedical Sciences, Vilnius University Faculty of Medicine, Vilnius, Lithuania.,Association of Medical Schools in Europe, Berlin, Germany
| | - V Vilc
- State Institute of Phtysiopulmonology by Chiril Draganiuk, Chisinau, Moldova
| | - T Alasevicius
- Department of Public Health, Institute of Health Sciences, and Clinic of Children's Diseases, Institute of Clinical Medicine, Vilnius University Faculty of Medicine, Vilnius, Lithuania.,European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium
| | - A Bedbrook
- MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France
| | - M Bewick
- iQ4U Consultants Ltd, London, UK
| | - J Chorostowska-Wynimko
- Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
| | - E Danila
- Clinic of Chest Diseases, Immunology and Allergology, Centre of Pulmonology and Allergology, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania
| | - A Hadjipanayis
- Medical School, European University of Cyprus, Nicosia, Cyprus
| | - R Karseladze
- Tbilisi State University Faculty of Medicine, Tbilisi, Georgia
| | - V Kvedariene
- Clinic of Infectious Chest Diseases, Dermatology and Allergology, Institute of Biomedical Sciences, Institute of Clinical Medicine, Vilnius University Faculty of Medicine, Vilnius, Lithuania
| | - E Lesinskas
- Clinic of ENT and Eye Diseases, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania
| | - L Münter
- Danish Commitee for Health Education, Copenhagen East, Denmark
| | - B Samolinski
- Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland
| | - S Sargsyan
- Institute of Child and Adolescent Health at Arabkir Medical Centre, Yerevan State Medical University, Yerevan, Armenia
| | - B Sitkauskiene
- Department of Immunology and Allergology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - D Somekh
- European Health Futures Forum (EHFF), Dromahair, Ireland
| | - L Vaideliene
- Clinic of Children's Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Algirdas Valiulis
- Department of Rehabilitation, Physical and Sports Medicine, Institute of Health Sciences, Vilnius University Medical Faculty, Vilnius, Lithuania
| | - P W Hellings
- Euforea, Brussels, Belgium.,Department of Otorhinolaryngology, University Hospital Leuven, Leuven, Belgium.,Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
5
|
Valiulis A, Bousquet J, Veryga A, Suprun U, Sergeenko D, Cebotari S, Borelli D, Pietikainen S, Banys J, Agache I, Billo NE, Bush A, Chkhaidze I, Dubey L, Fokkens WJ, Grigg J, Haahtela T, Julge K, Katilov O, Khaltaev N, Odemyr M, Palkonen S, Savli R, Utkus A, Vilc V, Alasevicius T, Bedbrook A, Bewick M, Chorostowska-Wynimko J, Danila E, Hadjipanayis A, Karseladze R, Kvedariene V, Lesinskas E, Münter L, Samolinski B, Sargsyan S, Sitkauskiene B, Somekh D, Vaideliene L, Valiulis A, Hellings PW. Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases. Clin Transl Allergy 2019; 9:7. [PMID: 30705747 PMCID: PMC6348633 DOI: 10.1186/s13601-019-0242-2] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2018] [Accepted: 01/04/2019] [Indexed: 01/18/2023] Open
Abstract
Background Over 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea. Conclusion The Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.
Collapse
Affiliation(s)
- A Valiulis
- 1Department of Public Health, Clinic of Children's Diseases, and Institute of Health Sciences, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.,European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium
| | - J Bousquet
- 3MACVIA-France, Fondation partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.,INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France.,5UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.,Euforea, Brussels, Belgium.,7Charité, Berlin, Germany
| | - A Veryga
- Minister of Health, Vilnius, Lithuania
| | - U Suprun
- Minister of Health, Kiev, Ukraine
| | - D Sergeenko
- Minister of Labour, Health and Social Affairs, Tbilisi, Georgia
| | - S Cebotari
- Minister of Health, Labour and Social Protection, Chișinău, Moldova
| | | | | | - J Banys
- Lithuianian Academy of Sciences, Vilnius, Lithuania
| | - I Agache
- 15Faculty of Medicine, Transylvania University, Brasov, Romania
| | - N E Billo
- Global Alliance Against Chronic Respiratory Diseases (GARD), Joensuu, Finland
| | - A Bush
- 17Imperial College and Royal Brompton Hospital, London, UK
| | - I Chkhaidze
- 18Department of Pediatrics, and Iashvili Central Children's Hospital, Tbilisi State Medical University, Tbilisi, Georgia
| | - L Dubey
- 19Faculty of Postgraduate Education, Lviv National Medical University by Danylo Halytsky, Lviv, Ukraine
| | - W J Fokkens
- 20Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands
| | - J Grigg
- 21Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK
| | - T Haahtela
- 22Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - K Julge
- 23Children's Clinic, Tartu University Institute of Clinical Medicine, Tartu, Estonia
| | - O Katilov
- Vinnytsa National Medical University by Mykola Pyrogov, Vinnytsa, Ukraine
| | - N Khaltaev
- Global Alliance Against Chronic Respiratory Diseases (GARD-WHO), Geneva, Switzerland
| | - M Odemyr
- 26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - S Palkonen
- 26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - R Savli
- 26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - A Utkus
- 27Department of Human and Medical Genetics, Institute of Biomedical Sciences, Vilnius University Faculty of Medicine, Vilnius, Lithuania.,Association of Medical Schools in Europe, Berlin, Germany
| | - V Vilc
- State Institute of Phtysiopulmonology by Chiril Draganiuk, Chisinau, Moldova
| | - T Alasevicius
- 1Department of Public Health, Clinic of Children's Diseases, and Institute of Health Sciences, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.,European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium
| | - A Bedbrook
- 3MACVIA-France, Fondation partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
| | - M Bewick
- iQ4U Consultants Ltd, London, UK
| | - J Chorostowska-Wynimko
- 31Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
| | - E Danila
- 32Clinic of Chest Diseases, Immunology and Allergology, Centre of Pulmonology and Allergology, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania
| | - A Hadjipanayis
- 33Medical School, European University of Cyprus, Nicosia, Cyprus
| | - R Karseladze
- 34Tbilisi State University Faculty of Medicine, Tbilisi, Georgia
| | - V Kvedariene
- 35Clinic of Infectious Chest Diseases, Dermatology and Allergology, Institute of Biomedical Sciences, Institute of Clinical Medicine, Vilnius University Faculty of Medicine, Vilnius, Lithuania
| | - E Lesinskas
- 36Clinic of ENT and Eye Diseases, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania
| | - L Münter
- Danish Commitee for Health Education, Copenhagen East, Denmark
| | - B Samolinski
- 38Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland
| | - S Sargsyan
- 39Institute of Child and Adolescent Health at Arabkir Medical Centre, Yerevan State Medical University, Yerevan, Armenia
| | - B Sitkauskiene
- 40Department of Immunology and Allergology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - D Somekh
- European Health Futures Forum (EHFF), Dromahair, Ireland
| | - L Vaideliene
- 42Clinic of Children's Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - A Valiulis
- 43Department of Rehabilitation, Physical and Sports Medicine, Institute of Health Sciences, Vilnius University Medical Faculty, Vilnius, Lithuania
| | - P W Hellings
- Euforea, Brussels, Belgium.,44Department of Otorhinolaryngology, University Hospital Leuven, Leuven, Belgium.,45Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
6
|
Zachariah R, Kumar AMV, Reid AJ, Van den Bergh R, Isaakidis P, Draguez B, Delaunois P, Nagaraja SB, Ramsay A, Reeder JC, Denisiuk O, Ali E, Khogali M, Hinderaker SG, Kosgei RJ, van Griensven J, Quaglio GL, Maher D, Billo NE, Terry RF, Harries AD. Open access for operational research publications from low- and middle-income countries: who pays? Public Health Action 2015; 4:142-4. [PMID: 26400799 DOI: 10.5588/pha.14.0028] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2014] [Accepted: 05/13/2014] [Indexed: 11/10/2022] Open
Abstract
Open-access journal publications aim to ensure that new knowledge is widely disseminated and made freely accessible in a timely manner so that it can be used to improve people's health, particularly those in low- and middle-income countries. In this paper, we briefly explain the differences between closed- and open-access journals, including the evolving idea of the 'open-access spectrum'. We highlight the potential benefits of supporting open access for operational research, and discuss the conundrum and ways forward as regards who pays for open access.
Collapse
Affiliation(s)
- R Zachariah
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - A M V Kumar
- International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India
| | - A J Reid
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - R Van den Bergh
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | | | - B Draguez
- MSF, Medical Department, Brussels Operational Center, Belgium
| | - P Delaunois
- MSF, General Direction, Luxembourg, Luxembourg
| | - S B Nagaraja
- Department of Community Medicine, Employees State Insurance Corporation Medical College and Post Graduate Institute of Medical Sciences and Research, Bangalore, India
| | - A Ramsay
- United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland ; University of St Andrews Medical School, Scotland, UK
| | - J C Reeder
- United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland
| | - O Denisiuk
- International HIV/AIDS Alliance, Kyiv, Ukraine
| | - E Ali
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - M Khogali
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - S G Hinderaker
- Centre for International Health, University of Bergen, Bergen, Norway
| | - R J Kosgei
- University of Nairobi, Obstetrics and Gynecology, Nairobi, Kenya
| | | | - G L Quaglio
- Science and Technology Option Assessment (STOA), Directorate-General for Parliamentary Research Services (EPRS), European Parliament, Brussels, Belgium
| | | | - N E Billo
- The Union, Centre for Operational Research, Paris, France
| | - R F Terry
- United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland
| | - A D Harries
- The Union, Centre for Operational Research, Paris, France ; London School of Hygiene & Tropical Medicine, London, UK
| |
Collapse
|
7
|
Affiliation(s)
- C-Y Chiang
- International Union Against Tuberculosis and Lung Disease, Paris, France ; Division of Respiratory Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
| | - N E Billo
- International Union Against Tuberculosis and Lung Disease, Paris, France
| | - D A Enarson
- International Union Against Tuberculosis and Lung Disease, Paris, France
| |
Collapse
|
8
|
Harries AD, Lin Y, Satyanarayana S, Lönnroth K, Li L, Wilson N, Chauhan LS, Zachariah R, Baker MA, Jeon CY, Murray MB, Maher D, Bygbjerg IC, Enarson DA, Billo NE, Kapur A. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 2011; 15:1436-44, i. [PMID: 21902876 DOI: 10.5588/ijtld.11.0503] [Citation(s) in RCA: 85] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
The prevalence of diabetes mellitus is increasing at a dramatic rate, and countries in Asia, particularly India and China, will bear the brunt of this epidemic. Persons with diabetes have a significantly increased risk of active tuberculosis (TB), which is two to three times higher than in persons without diabetes. In this article, we argue that the epidemiological interactions and the effects on clinical presentation and treatment resulting from the interaction between diabetes and TB are similar to those observed for human immunodeficiency virus (HIV) and TB. The lessons learned from approaches to reduce the dual burden of HIV and TB, and especially the modes of screening for the two diseases, can be adapted and applied to the screening, diagnosis, treatment and prevention of diabetes and TB. The new World Health Organization (WHO) and The Union Collaborative Framework for care and control of TB and diabetes has many similarities to the WHO Policy on Collaborative Activities to reduce the dual burden of TB and HIV, and aims to guide policy makers and implementers on how to move forward and combat this looming dual epidemic. The response to the growing HIV-associated TB epidemic in the 1980s and 1990s was slow and uncoordinated, despite clearly articulated warnings about the scale of the forthcoming problem. We must not make the same mistake with diabetes and TB. The Framework provides a template for action, and it is now up to donors, policy makers and implementers to apply the recommendations in the field and to 'learn by doing'.
Collapse
Affiliation(s)
- A D Harries
- International Union Against Tuberculosis and Lung Disease, Paris, France; London School of Hygiene & Tropical Medicine, London, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Enarson DA, Rusen ID, Chiang CY, Harries AD, Billo NE. Health systems that serve: what's the bottom line? Int J Tuberc Lung Dis 2009; 13:804-809. [PMID: 19555528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
SETTING Health services in low- and middle-income countries. BACKGROUND The Global Plan to Stop TB, 2006-2015. OBJECTIVE Using a framework for evaluation of public health systems, to evaluate evidence that tuberculosis (TB) services contribute to strengthening the health systems. DESIGN Critical evaluation of published material. RESULTS The Global Plan to Stop TB 2006-2015 identifies strengthening the health systems as one of its components. Published material illustrates substantial improvement of quality of TB services over the past decade. However, even where these services have achieved a high level of quality, there is little evidence to indicate that other health services in the same locations show similar quality. CONCLUSION Policies, strategies and actions to strengthen health systems through TB services will require specific plans and priorities to achieve their objectives; this will not occur as a natural effect of improving TB services.
Collapse
Affiliation(s)
- Donald A Enarson
- International Union Against Tuberculosis and Lung Disease, Paris, France.
| | | | | | | | | |
Collapse
|
10
|
Abstract
Asthma is a worldwide public health problem affecting about 300 million people. The majority of persons living with asthma are in the developing world where there is limited access to essential drugs. The financial burden for persons living with asthma and their families, as well as for healthcare systems and governments, is very high. Inadequate treatment and the high cost of medications leads to disability, absenteeism and poverty. Despite the existence of effective asthma medications and international guidelines, and progress made in the implementation of such guidelines over the last decade, the high cost of essential asthma medications remains a major obstacle for patient access to treatment in developing countries. The International Union Against Tuberculosis and Lung Disease has evaluated this problem and created an Asthma Drug Facility (ADF) so that countries can purchase affordable, good quality essential drugs for asthma. The ADF uses pooled procurement along with other purchasing and supply strategies to obtain the lowest possible prices. Accompanied by the implementation of standardized asthma management, the increased affordability of drugs provided by the ADF should bring rapid and significant health and cost benefits for patients, their communities and governments.
Collapse
Affiliation(s)
- N Ait-Khaled
- International Union against Tuberculosis and Lung Disease (The Union), Paris, France
| | | | | | | |
Collapse
|
11
|
Billo NE. Asthma drug facility: from concept to reality. Int J Tuberc Lung Dis 2006; 10:709. [PMID: 16848329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023] Open
|
12
|
Billo NE. Do we need an asthma drug facility? Int J Tuberc Lung Dis 2004; 8:391. [PMID: 15141728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023] Open
|
13
|
Aguilar R, Garay J, Villatoro M, Billo NE, Caminero JA. Impact of a model training course for private and public specialist physicians in El Salvador. Int J Tuberc Lung Dis 2004; 8:473-9. [PMID: 15141741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023] Open
Abstract
BACKGROUND Private and non-private specialist practitioners are often considered an obstacle to the performance of the National Tuberculosis Control Programme (NTP). OBJECTIVE To evaluate the impact of an intensive refresher course directed at specialist physicians in El Salvador, a questionnaire was sent to all course participants on their basic knowledge of tuberculosis (TB) control. RESULTS Of 64 participants, 55 were assessed (86%); 33 were chest physicians and 22 belonged to other related specialities. The evaluation showed a considerable improvement in both groups in their ability to suspect the disease, in their tendency to avoid hospitalising patients and instead refer them to out-patient clinics, and in their adherence to the recommendations of the NTP manual (diagnostic procedures, treatment guidelines, case notification and cohort studies). Improvements were more noticeable, in all the parameters evaluated, among the non-chest physicians. CONCLUSION The intervention model succeeded in improving the collaboration of private and non-private specialist practitioners with the NTP.
Collapse
Affiliation(s)
- R Aguilar
- National Hospital Rosales, San Salvador, El Salvador
| | | | | | | | | |
Collapse
|
14
|
Abstract
BACKGROUND This study describes the epidemiological trends of tuberculosis in Cuba and the performance of the tuberculosis control programme. The circumstances that caused an increase in the incidence of new cases of tuberculosis between 1991 and 1994 had been analysed and were corrected in 1995-7. METHODS A descriptive study of the incidence rates of new cases of tuberculosis notified from 1962 to 1997 was made, with special emphasis on the total change between 1965 and 1991 and the increase thereafter. RESULTS The case notification rate of 14.7 per 100 000 in 1994 was almost three times the rate found in 1991 (4.8 per 100 000) and reversed the mean annual decrease of 5% observed since 1965. This increase was almost twofold in the rate of smear positive new cases (4.4 per 100 000 in 1991 and 8.3 in 1994). From 1971 onwards the programme had achieved a cure rate of 90% throughout the country with only 2% absconding by applying directly observed treatment. The main factors associated with the increasing trends were: (1) a probable underdetection of cases for the 1988-92 period that generated contagious sources in the community; (2) improved case finding from 1993 onwards and the introduction of an expanded case definition in 1994; (3) a considerable increase in the diagnostic delay from initial medical consultation to beginning of antituberculosis treatment (56.9 days in 1993); and (4) operational changes in the tuberculosis control programme due to the economic crisis in Cuba. In 1995, 1996 and 1997 it has been possible to reverse this trend, achieving rates of 14.1, 13.5, and 12.2 per 100 000, respectively (7. 6, 7.6, and 6.9 for smear positive cases) as a result of effective intervention correcting the problems identified. Reducing the diagnostic delay attributable to shortcomings in the health care system and the study of contacts were of particular importance for re-establishing the tuberculosis programme as a priority. CONCLUSIONS Cuba represents a good example of how it is possible to fight against tuberculosis effectively, even in a low income country, by applying control strategies advocated by the World Health Organisation and the International Union Against Tuberculosis and Lung Disease and by giving adequate support to the programme through political commitment.
Collapse
Affiliation(s)
- A Marrero
- National Tuberculosis Programme of the Ministry of Public Health, Cuba
| | | | | | | |
Collapse
|
15
|
Billo NE. [Epidemiologic trends in tuberculosis]. Rev Prat 1996; 46:1332-5. [PMID: 8794615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
More than 90% of all tuberculosis cases occur in developing countries. Incidence rates estimated by WHO vary from 23 per 100,000 in industrialized countries to 191 per 100,000 in Africa and 237 per 100,000 in South East Asia. the downward trend observed in most industrialized counties in the 1970's and 1980's caused a neglect that nearly made tuberculosis a forgotten disease among the medical profession and policy makers. Ths neglect has led to a catastrophe in certain large cities in the United States. The resurgence of tuberculosis can not be attributed to the HIV/AIDS epidemic alone but also to the dismantling of health care structures responsible for tuberculosis control in certain countries.
Collapse
|
16
|
Billo NE. [The worldwide status of tuberculosis today]. Pneumologie 1995; 49 Suppl 3:633-5. [PMID: 8577667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- N E Billo
- Internationale Union gegen Tuberkulose und Lungenkrankheiten, Paris, Frankreich
| |
Collapse
|
17
|
Malinverni R, Müller M, Billo NE. [HIV infection: survey among practicing physicians in Bern]. Schweiz Med Wochenschr 1992; 122:993-1004. [PMID: 1626252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
With increasing numbers of HIV-infected patients, practitioners will play a crucial role in the prevention of HIV infection and in the care of infected persons. To assess the need for accurate education programs we investigated by questionnaire the current practice, attitudes and knowledge of 1057 practitioners (general, internists, surgeons, dermatologists, gynecologists), on care, prevention and treatment of HIV infection and HIV-related problems in the Canton of Berne (population 1 million), Switzerland. 65% of the practitioners provided completely evaluable responses. More than 90% had already prescribed HIV tests by the end of 1989. A majority rejected routinely performed tests (e.g. for all pregnant women, for all patients before surgery). Only about 50% considered a patient's informed consent mandatory before each test. Primary prevention by sexual history-taking was only rarely done in current practice. All recommendations from the Swiss "Stop Aids" campaign were supported, and even experimental measures such as allowing i.v. drug use in street corner agencies or controlled distribution of heroin were supported by the majority. Mandatory testing of risk groups was favored by about 50% but almost nobody wanted to establish name records of persons with risk behaviour. By the end of 1989 about one third of practitioners regularly cared for HIV-infected persons. Most practitioners would prefer to care independently for asymptomatic HIV-infected persons, but would favor a specialist support when caring for symptomatic patients. Lack of medical skills and knowledge was the main reason for their reluctance in caring for patients. Skilled and experienced practitioners were more prone to care for additional patients and were more active in prevention. Knowledge about HIV transmission, HIV-related complications and treatment was good among general practitioners and internists. However, there was some confusion about the indications for active vaccination in Aids patients. The readiness of Bern practitioners to care for HIV-infected persons is already large and could be increased by improving their medical knowledge. However, it is unlikely that more medical information alone will improve their prevention activities. It appears that education programs aimed at improving the prevention activities of practitioners are best designed and performed by their skilled and experienced colleagues.
Collapse
Affiliation(s)
- R Malinverni
- Medizinische Universitätspoliklinik, Inselspital Bern
| | | | | |
Collapse
|
18
|
Raeber PA, Billo NE, Rieder HL, Somaini B. [Medical examination of asylum seekers at entry]. Ther Umsch 1990; 47:844-51. [PMID: 2260026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
It was the purpose of this analysis to summarize the salient findings made with the initial medical examination of asylum seekers in Switzerland. The evaluation covered the period from 1984 to 1987. The epidemiologic impact of diseases discovered by this screening and the logistic problems encountered with the decentralization of the program have required a modification and a reassessment of the necessary measures. As a consequence, indiscriminate stool examinations for bacteria and parasites have been abandoned. These examinations had required a considerable investment which is not considered to be justified by the limited epidemiologic significance of these intestinal pathogens. More emphasis is being placed on improved tuberculosis control measures, by providing concise guidelines for screening, prevention, and treatment. A simplified procedure for hepatitis B screening is to be maintained for the time being, conditional upon special emphasis on children, adolescents and adults of reproductive age groups. Hepatitis B vaccination of seronegative persons is a part of the standard basic immunization program. The core of the screening program and the delivery of initial preventive measures is to be carried out in the federal registration and transit centers for asylum seekers.
Collapse
Affiliation(s)
- P A Raeber
- Bundesamt für Gesundheitswesen (BAG), Bern
| | | | | | | |
Collapse
|
19
|
Rieder HL, Zimmermann H, Zwahlen M, Billo NE. [Epidemiology of tuberculosis in Switzerland]. Schweiz Rundsch Med Prax 1990; 79:675-9. [PMID: 2349426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Mortality for tuberculosis declined from an average of 7.5% per year in 1952 to 1.7 in 1988, tuberculosis incidence declined by 5 to 6% per year since 1945 to 17.4% in 1988, and the annual risk of infection declined by 11.4% per year since 1945 to 10.9 per 100,000 inhabitants respectively. The crude prevalence of tuberculous infection in the Swiss population is estimated to be 22.3% for the year 1990. The age-specific prevalence of infection is mirrored in age-specific morbidity. Among Swiss citizens, tuberculosis has become a disease of the elderly and is on the brink of elimination. In contrast, tuberculosis among foreigners (40% of cases in 1988) occurs mainly among the young who experience a more than 10-fold elevated risk compared to their Swiss age peers. These data suggest that case-finding and contact investigations are the major intervention tools against tuberculosis in the Swiss population. The increased tuberculosis risk among foreigners and the young age of these patients suggest that identification of those at high risk and their preventive treatment will have to be pursued actively.
Collapse
|
20
|
Billo NE, Hohl PE, Winteler S. [Epidemiology of legionnaires' disease in Switzerland in 1988]. Schweiz Med Wochenschr 1989; 119:1859-61. [PMID: 2692149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Both sporadic cases and outbreaks of legionnaire's disease have been reported. To date, no outbreaks have occurred but several case reports have been published in Switzerland. The newly organized surveillance system of notifiable diseases, introduced in 1987, makes it possible for the first time to analyze reported sporadic cases more precisely. In 1988, the laboratories reported a total of 32 cases with cultural or serologic proof of legionellosis. In 75% of cases patients were aged over 40 years, 78% occurred among males. The majority of them were known to be smokers. In 9 cases an underlying predisposing condition was known: hairy cell leukemia (3 cases), immune hemolytic anemia (1), type 2 diabetes (2), chronic lung disease (1), heart failure (1). The case fatality was 9%. A possible source of exposure, such as air-conditioned rooms or evaporative condensers, was reported in 4 cases.
Collapse
Affiliation(s)
- N E Billo
- Bundesamt für Gesundheitswesen, Medizinische Abteilung, Bern
| | | | | |
Collapse
|